Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)

CAPS Rating: 4 out of 5

A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.

SPPI News and Commentary

Caps

How do you think SPPI will perform against the market?

Add Stock to CAPS Watchlist

All Players

419 Outperform
12 Underperform
 

All-Star Players

52 Outperform
2 Underperform
 

Wall Street

9 Outperform
1 Underperform
 

Top SPPI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.83)
Submitted January 09, 2014

It looks like I've only got six slots left for CAPS picks and I'm going to blow one of them on Spectrum, a company I've been critical of in the past but could be turning a corner. After several quarters of decline in Fusilev revenues, there was a… More

pavlos1971 (99.00)
Submitted March 13, 2013

From @adamfeuerstein's tweet: "$SPPI -- What happened? 1) Wholesalers didn't order any Fusilev in Q1 2) Hospital demand for Fusilev fell off cliff due to generics."

SPPI VS S&P 500 (SPY)

Fools bullish on SPPI are also bullish on:

Fools bearish on SPPI are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SPPI.

Recs

0
Member Avatar DADDYBLAME (71.28) Submitted: 6/9/2017 10:46:16 AM : Outperform Start Price: $5.92 SPPI Score: +223.70

My broker picked me up a few shares back in 2011. Added over the years in small amounts until had 400 shares total leaking money left and right. I kept hoping to see something to validate keeping this investment but it just kept getting worse. Sometimes I am stubborn and make rookie mistakes, there is no excuse for this dog but still have this in my portfolio. After last quarter (Feb 17) I decided to give it til first half of 2018 before just letting it go into the ether, "Oh the humanity", never in a million years will i make this mistake twice, but probably will, it's the human condition after all

Recs

0
Member Avatar loangolfer (< 20) Submitted: 5/1/2015 9:32:57 AM : Outperform Start Price: $5.73 SPPI Score: +217.27

ZZlanger likes it and he is all over these bio-med things.

Recs

5
Member Avatar zzlangerhans (99.83) Submitted: 1/8/2014 11:56:59 PM : Outperform Start Price: $8.54 SPPI Score: +88.27

It looks like I've only got six slots left for CAPS picks and I'm going to blow one of them on Spectrum, a company I've been critical of in the past but could be turning a corner. After several quarters of decline in Fusilev revenues, there was a sharp uptick last quarter which may indicate that Fusilev has acquired a foothold from which they won't be easily displaced by the reappearance of generic leucovorin. Zevalin and Folotyn are performing respectably, and pivotal data for captisol-enabled melphalan in Q2 could provide further lift. There will also likely be a PDUFA for Belinostat in late 2014. Marqibo and apaziquone are the wild cards in the mix, but there is certainly potential for positive catalysts with phase III trials in 2014.

A former high flyer, Spectrum was anemic in the biopharma bull market of 2013. Raj got his bonus in 2012 and seems to be resting on his laurels for now, but I believe eventually the potential here will lift the stock even in the absence of self-promotion.

Leaderboard

Find the members with the highest scoring picks in SPPI.

Score Leader

jms75

jms75 (< 20) Score: +407.44

The Score Leader is the player with the highest score across all their picks in SPPI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
jms75 < 20 11/12/2007 Outperform 5Y $3.29 +493.48% +86.04% +407.44 0 Comment
dough99999 21.44 8/6/2007 Outperform 1Y $3.51 +455.13% +88.23% +366.90 0 Comment
comccart 61.39 8/8/2007 Outperform 3M $3.71 +425.61% +82.90% +342.70 0 Comment
Megalomania < 20 7/26/2007 Outperform 1Y $3.89 +401.59% +80.74% +320.86 0 Comment
stockman132 66.35 10/8/2007 Outperform 1Y $4.08 +378.52% +74.47% +304.05 0 Comment
hudicek7 < 20 10/23/2007 Outperform 1Y $4.08 +377.37% +79.27% +298.10 0 Comment
lazzzzar < 20 5/8/2009 Outperform 1Y $3.41 +471.18% +181.49% +289.68 0 Comment
nicmatzen 22.88 8/9/2007 Outperform 3M $4.14 +370.55% +84.21% +286.34 0 Comment
hooligan1901 < 20 8/27/2007 Outperform NS $4.16 +368.31% +83.59% +284.72 0 Comment
LowPoints < 20 7/7/2010 Outperform 5Y $3.69 +428.41% +150.03% +278.38 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCreditSuiss 90.62 6/24/2013 Underperform NS $7.58 +157.26% +63.81% -93.44 0 Comment
TrackBurrillInst < 20 5/29/2013 Outperform NS $8.57 +127.54% +55.88% +71.66 0 Comment
TrackZacks < 20 8/31/2012 Underperform 3M $11.96 -7.36% -2.13% +5.23 11/9/2012 @ $11.08 1 Comment
TrackUltraLong < 20 7/31/2012 Outperform NS $13.80 +41.26% +86.26% -45.00 1 Comment
TrackTMFFoolish8 < 20 5/22/2012 Outperform 5Y $11.44 +3.31% +5.94% -2.62 8/31/2012 @ $11.82 0 Comment
TrackJimCramer 85.15 3/21/2012 Outperform 3W $13.06 +49.27% +83.91% -34.64 0 Comment
TrackAurigaUSA 55.50 9/30/2011 Outperform NS $7.44 +162.11% +125.30% +36.80 0 Comment
trackmlvcapital 24.95 5/2/2011 Outperform NS $9.74 +100.15% +88.95% +11.20 0 Comment
TrackRBCCapMkts 88.54 3/25/2011 Outperform NS $8.38 +132.78% +96.48% +36.30 0 Comment
TrackJimCramer 85.15 3/25/2011 Underperform 3W $8.58 +54.37% +6.79% -47.58 3/22/2012 @ $13.25 0 Comment
TrackMorganJos 82.15 1/12/2010 Outperform NS $4.93 +295.26% +126.25% +169.00 0 Comment
TrackRodmanRen < 20 10/31/2007 Outperform NS $3.67 +431.26% +75.44% +355.83 0 Comment
TrackBreanMurray 80.06 10/9/2007 Outperform NS $4.35 -47.13% -15.96% -31.17 3/18/2008 @ $2.30 0 Comment
TrackLazardCapit 77.11 7/25/2007 Outperform NS $3.96 +392.83% +79.38% +313.46 0 Comment
TrackBreanMurray 80.06 7/24/2007 Underperform NS $4.92 -16.67% -1.26% +15.41 7/25/2007 @ $4.10 0 Comment
TrackFBRCapitalM 90.33 5/24/2007 Outperform NS $6.42 -36.14% -0.19% -35.95 7/25/2007 @ $4.10 0 Comment
TrackBreanMurray 80.06 4/11/2007 Outperform NS $6.85 -26.57% +6.87% -33.44 7/23/2007 @ $5.03 0 Comment
TrackOppenheimer 70.07 12/6/2006 Outperform NS $5.80 -72.07% -2.68% -69.39 4/23/2008 @ $1.62 0 Comment

Featured Broker Partners